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In depth characterisation 
of the biomolecular coronas 
of polymer coated inorganic 
nanoparticles with differential 
centrifugal sedimentation
André Perez‑Potti1,2, Hender Lopez1,3, Beatriz Pelaz5,6, Abuelmagd Abdelmonem4,7,8, 
Mahmoud G. Soliman4,9,10, Ingmar Schoen12, Philip M. Kelly1, Kenneth A. Dawson1, 
Wolfgang J. Parak4, Zeljka Krpetic1,11* & Marco P. Monopoli1,9* 
Advances in nanofabrication methods have enabled the tailoring of new strategies towards the 
controlled production of nanoparticles with attractive applications in healthcare. In many cases, 
their characterisation remains a big challenge, particularly for small‑sized functional nanoparticles of 
5 nm diameter or smaller, where current particle sizing techniques struggle to provide the required 
sensitivity and accuracy. There is a clear need for the development of new reliable characterisation 
approaches for the physico‑chemical characterisation of nanoparticles with significant accuracy, 
particularly for the analysis of the particles in the presence of complex biological fluids. Herein, 
we show that the Differential Centrifugal Sedimentation can be utilised as a high‑precision tool 
for the reliable characterisation of functional nanoparticles of different materials. We report a 
method to correlate the sedimentation shift with the polymer and biomolecule adsorption on the 
nanoparticle surface, validating the developed core–shell model. We also highlight its limit when 
measuring nanoparticles of smaller size and the need to use several complementary methods when 
characterising nanoparticle corona complexes.
Progressive advancements in nanofabrication approaches have led to the development of nanoparticles (NP) of 
various core materials, size and shape that have found applications in a broad range of sectors, from life science, 
and electronics to energy harvesting. The NP used as a platform in healthcare has also raised significant interest 
due to the development of NP-based medical devices for biomolecular sensing, diagnostics, and also nanovectors 
for drug delivery in cancer  treatment1–3.
Despite these numerous applications, these advanced functional nanomaterials require precise control of the 
surface chemistry to enable targeting, sensing, and drug delivery. With the addition of drugs or other functional 
moieties to the NP ligand shells, the characterisation of the functionalised particles can become complex, requir-
ing multiple analytical techniques to provide a full picture and achieve a robust characterisation to enable use 
in clinical trials and  nanomedicine4.
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NPs are often subjected to a range of controlled stages at the manufacturing process, spanning from pro-
duction to purification, through to characterisation and integration in consumer products. Where applicable, 
nanomaterials must comply with required regulatory legislation and  standards5,6.
Due to their unique size and surface properties, NPs have the potential to engage with cellular machinery with 
high affinity, precision and specificity opening up the potential for tailoring their biodistribution; though in vivo 
targeting remains a major  issue7,8. In many in vitro and in vivo scenarios, NPs strongly interact with proteins 
and other biomolecules readily available in biological fluids to which they are exposed to, often forming the so 
called ‘biomolecular corona’9–11. From many reports, it is clear that the biomolecular corona may impact the 
identity and alter the behaviour of the NPs depending on its composition and topological organisation, leading 
to the presence of specific motifs i.e. epitopes of the adsorbed biomolecules, prone to be recognised with high 
affinity and specificity by the cell receptors, and therefore often steering the interactions and uptake  routes12–18.
In addition to the formation of altered biological identity, the biomolecular corona may also influence the 
physico-chemical properties of the NPs, e.g. dispersion, hydrodynamic diameter, surface charge, colloidal stability 
and degradation, which can impact their pharmacokinetic properties and  biodistribution19–23.
NPs of 5 nm diameter or smaller are gaining attention in the field of  nanomedicine24. In contrast to the larger 
ones, these nanomaterials offer improved tissue penetration, a reduced accumulation in the liver and more effi-
cient renal  clearance25, which renders them particularly attractive for reducing the non-specific accumulation 
and off-target effects.
Within this context, metallic NPs, such as gold (AuNPs) or semiconductor quantum dots (QDs) have become 
a popular choice. They can be easily synthesised in a size-controlled manner, within the desirable size range, 
with good size monodispersity, high batch reproducibility and highly tuneable surface chemistry which allows 
for a tailored  design21. They are generally synthesised in an organic media using a biocompatible polymers, e.g. 
polyethylene glycol or chitosan amongst others, which is grafted onto the NP surface to ensure colloidal stability 
during the phase transfer into the aqueous media. The addition of this layer inevitably leads to a small increase 
in their diameter and changes in the overall density. This layer is however essential to ensure the colloidal stabil-
ity even after the exposure to physiological  solutions1,26. As such, characterisation of the newly functionalised 
particles is of utmost importance to ensure successful surface functionalisation and monitor particle stability 
over time under a variety of dispersion  conditions4.
Despite the broad interest, current limitations in the use of small NPs were reported due to the challenges 
associated with their physico-chemical characterisation, e.g. size distribution measurements, in particular after 
 bioconjugation27, commonly characterised using commercially available techniques such are Dynamic Light 
Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) which struggle to analyse such challenging objects 
due to their detection limit and other  issues28,29. Other techniques, such as Fluorescence Correlation Spectros-
copy (FCS) or agarose gel electrophoresis (AGE) require particular particle properties (e.g. fluorescence) and 
are not broadly applicable to all NP  types4. Recent studies reported the use of analytical or ultra-centrifugation 
as an alternative method to characterise the particle size distribution of a wide range of  nanomaterials30–32. The 
establishment of a characterisation method to reliably study the NP characterisation after exposure in complex 
biological media (e.g. human plasma or serum) or in situ is still required so that the reproducibility and confi-
dence in the production of such materials is achieved.
In this manuscript, we developed a series of inorganic NPs of ca. 5 nm core diameters, i.e. with a core of gold, 
CdSn/ZnS quantum dots, silver, or iron platinum functionalised with a commonly used versatile and biocom-
patible polymer, poly-(isobutylene-alt-maleic anhydride)-graft-dodecyl (PMA)4, along with a series of AuNPs 
of three different sizes but same surface coating, and we used Differential Centrifugal Sedimentation (DCS), an 
emerging technique of growing popularity for  the NP characterisation.
The DCS is a simple technique that measures the size distribution based on the sedimentation time of a 
particle through a sucrose density gradient placed in a spinning disc. Under these conditions, the particles will 
separate according to their size and density. During a typical experimental run, the instrument measures the 
time that elapses from the moment in which the NPs enter the gradient and reach the detector. From this time, 
the NP diameter is calculated using modified Stoke’s law. However, when a NP is coated with a polymer or with 
a biomolecule and its resulting density and size is changed, the NP sedimentation size will be altered, and the 
size mesured by the DCS is not correct. Therefore, the identification of the “true” NP size from the "apparent" 
size obtained in DCS measurements requires using a simple core-shell model that takes into account the new 
NP density. DCS allows a high-resolution separation and detection of a small percentage of particle populations 
within the polydisperse colloidal samples analysed that are not detectable by other techniques, and can also 
provide useful information on the surface functionalisation with stabilising ligands and overall colloidal stability 
after biomolecular  interaction13,33,34.
Additionally, while on the manufacturer information the DCS is claimed to be capable of measuring the NP 
size in the range between 3 nm and 60 μm, most studies to date are focused on NP with diameters of 20 nm or 
larger and with high density. For consistency and validation of our results, we compared the particle size meas-
urements obtained from DCS measurements of the 5 nm core particles with a wider set of particles of the same 
core material but of larger particle diameter, i.e. 25 and 50 nm. Finally, we characterised these nanomaterials after 
exposure to blood plasma, a biological fluid of particular interest used in nanomedicine and nanosafety studies.
Herein, we highlight the main challenges associated with sizing polymer functionalised inorganic NP, using 
a core–shell sedimentation model (Scheme 1) and we show the differences in the sedimentation behaviour not 
commonly occurring with particles of larger diameters.
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Results and discussion
Determination of particle size distribution of polymer‑coated NPs via DCS technique. Spheri-
cal gold NPs of 5 nm diameter were synthesised following Brust-Shiffrin  method35. While the NP synthesis was 
carried out in toluene, we applied a polymeric surface grafting using a hydrophilic layer of poly-(isobutylene-
alt-maleic anhydride)-graft-dodecyl (PMA), necessary to facilitate the phase transfer from toluene into the 
water, that also ensures particle stability in aqueous  media36,37. Particles were sized using Transmission Electron 
Microscopy (TEM) showing an average core diameter of 4.8 ± 0.7 nm while the organic surface coating was not 
visible with this technique (Fig. 1a,b, Table 1)4. The particle stability was assessed with DCS and comparable 
particle size distribution of the TEM measurements was also obtained for the NP cores (Fig. 1c,d—black line, 
Table 1). Following the PMA coating and subsequent transfer to aqueous media, DCS measurements were per-
formed on the coated NPs, resulting in a shift towards an apparent smaller diameters (left shift from the pristine 
uncoated particles) (Fig. 1c,d—red line). A broadening of the NP-protein corona peak was observed for the 
5 Au-PMA particles only, indicating the presence of particles dimers or the presence of a NP population that 
absorbed corona proteins differently. 
Core‑shell model calculations. The DCS measures the time it takes for the injected NPs to sediment and 
reach the light source (measuring point) whilst travelling through a linear density gradient fluid in a spinning 
hollow disc at a fixed rotational speed. During the measurement, the DCS software is using pre-set particle den-
sity values that are kept constant and equal to the one of the core materials for all measurements in accordance 
with the equation below:
where ρeff  is the density of the NP, ρfl is the density of the fluid, and C a constant determined by a calibration 
process. Prior to each measurement, the value of the particle density ( ρeff  ) is assumed. For a single component 
NP, e.g. a naked metallic core, its density is well known, and its size can be accurately determined, whereas, for 
composite nanomaterials, the density can often be estimated based on the known densities of the constituent 
materials (e.g. gold core has a known density of 19.3 g  cm−3). However, when NPs are composed of several lay-
ers of different materials, ρeff  has to be estimated in order to calculate their overall  diameter12,13. Typically, the 
addition of a ligand in the particle ligand shell lowers the overall particle density (ρeff, in Eq. (2)), as the density 
of the ligand is often significantly lower than the one of the particle core material (Scheme 2).
A common way to estimate ρeff  is by the use of the core–shell  model33 which assumes that the composite NP 
is composed of a core of known density and a number of different well defined layers, each of them with its own 
thickness and density. By calculating the total mass of the NP, which depends on the density and the thickness 






Scheme 1.  (a) Schematic showing the proposed complex core–shell model used for the analysis of the particle 
diameter by Differential Centrifugal Sedimentation (DCS) for polymer functionalised inorganic nanomaterial 
forming the NP-biomolecular corona complexes containing several layers of different intrinsic thickness and 
density. (b) dc nanoparticle core diameter; s1: shell thickness of the polymer coating; s2: protein corona shell 
thickness. Scheme drawn with Microsoft PowerPoint and the proteins structures were adapted from the Protein 
Data Bank (http:// www. pdb. org).
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while for the case of a core and two coating layers ρeff  is given by Eq. (3):
where dc is the diameter of the core, s1 is the thickness of the first layer, s2 is the thickness of the second layer, and 
ρc , ρs1 and ρs2 are the densities of the core, the first layer, and the second layer, respectively (Scheme 1).
(2)ρeff =
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Figure 1.  Characterisation of PMA coated AuNPs of different sizes by TEM and DCS. Measurements for 
5, 25 and 50 AuNPs are shown respectively in the top (a–d), middle (e–h) and bottom (i–l) panels. TEM 
measurements were performed on the polymer-coated NPs. Representative micrographs for each of the 
different sizes (a,e,i) and the resulting histogram counts (b,f,j) are provided with average core diameters of 
4.8 ± 0.7, 26.9 ± 3.4 and 47.6 ± 5.7 nm respectively. DCS measurements were performed for the three relevant 
NP suspensions, i.e. AuNPs in the organic solvent (toluene) prior to PMA coating (black line), the Au-PMA 
polymer-coated NPs after water transfer (red line) and Au-PMA-Corona complexes in situ measured after 
corona formation (blue line). Representative DCS distributions are provided for each of the NP sizes (c,g,k) 
along with the detailed average and standard deviations across independent replicates (d,h,l). Particle diameters 
obtained from DCS measurements assumed a particle density of 19.3 g  cm-3.
Table 1.  Average NP diameter and standard deviation of the gold NPs prior to and after exposure with the 
biological fluid, measured by different characterisation methods. Particle diameters obtained from DCS 
measurements assumed a particle density of 19.3 g  cm-3.
Particle diameter, d (nm) 5 Au 25 Au 50 Au
TEM core (nm) 4.8 ± 0.7 26.9 ± 3.4 52.0 ± 7.5
DCS core (nm) 4.5 ± 0.6 26.3 ± 4.0 51.4 ± 2.4
DCS Au-PMA (nm) 2.4 ± 0.2 22.6 ± 0.1 46.8 ± 0.2
DCS Au-PMA-C (nm) 2.3 ± 0.2 22.3 ± 0.1 43.1 ± 0.6
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In practice, the size of a coated NP is determined with the following expression (Eq. (4)):
where dNP is the total diameter of the NP which is d2NP +  2s1 for the one-layer case and dc +  2s1 +  2s2 for the two-
layer case, and dDCS is the NP size as measured with the DCS.
Since the shell not only changes the effective density of the NP but also its size, coupling these two effects will 
affect the particle sedimentation time in a non-trivial manner, as shown in Fig. 2. For a NP with a core density 




/3 will always 
lead to a faster sedimentation, whereas a density ρs < ρfl will always result in longer sedimentation times, or no 
sedimentation at all, if the NP becomes effectively less dense than the medium itself (Fig. 2a, upper left corner). 
A shell with a density between these two limits can either slow down or accelerate sedimentation depending 
on its thickness. For thin shell coatings, the reduced effective NP density dominates and slows down the sedi-
mentation, while for thicker shells, the larger size dominates and speeds up the sedimentation. At the boundary 
between these two regimens, particular combinations of shell thicknesses and densities do not change the NP 









Scheme 2.  Schematic representation of the DCS measurements of bare and coated AuNPs. As described in 
Eqs. (1)–(3), the NP sedimentation time under a centrifugal force is directly correlated to their effective density. 
In the case of a bare AuNP, the effective density ρeff is close to the theoretical value (i.e. 19.3 g  cm−3) while for a 
polymer coated AuNP, the effective density is affected (as described in the Eq. (3)) and also the sedimentation 
time. Scheme drawn with Adobe Photoshop.
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the sedimentation time increases with increasing the shell thickness up to a maximum (red dashed curve) 
before it decays again and becomes shorter than the sedimentation time of the bare NP (solid black curve, see 
also Fig. 2b). As an important consequence, increased sedimentation time is not related to a unique shell thick-
ness for intermittent shell densities, but rather can, in theory, correspond to two different thicknesses. In the 
practical situation (see Scheme 1), the density of the polymer coating (shell thickness s1) and the density of the 
biomolecular corona (shell thickness s2) is much closer to the density of the surrounding medium than to the 
density of the core of gold NPs and the maximum sedimentation time would occur at a shell thickness of ca. 2.5 
times the NP core diameter dc (Fig. 2b, blue curve). For the smallest NP core diameter in this study (5 nm), this 
corresponds to a protein layer of 12.5 nm thickness. Since most proteins adsorb side-on and have a width in the 
range of 10 nm, thus less than 2.5 times the NP core diameter, an increase in shell thickness always results in an 
increase in sedimentation time. Therefore, as an output, the instrument will report a smaller apparent diameter 
as a result of the surface coating added.
Note, that also the 5 nm AuNP cores are coated with a thin organic ligand shell (dodecanethiol) before the 
polymer coating is added, and thus in principle the system might result with a core–shell system with different 
densities. However, when we considered the thin dodecanethiol shell a negligible change was observed and hence 
this it is not taken into account. Opposed to this, after the polymer coating addition, DCS measurements of 5 nm 
AuNPs coated with the PMA polymer of 2.4 ± 0.2 nm, resulting in a shift from the NP uncoated core of 2.1 nm 
(Fig. 1c,d, Table 1). Such shift confirms a change in the NP density and successful coating of the particles with the 
polymer, shown by the lack of any additional (side) peaks appearing, suggesting lack of any aggregation events.
We then evaluated whether the DCS could provide meaningful information on the particle’s colloidal stability 
after the exposure with a complex biological fluid, e.g. human plasma, in order to characterise the NP-biomo-
lecular corona complexes (Au-PMA-C). For this purpose, we characterised NP-biomolecular corona complexes 
“in situ”, after incubation in blood plasma and without the removal of the excess of plasma (Fig. 1c,d, blue line) 
by centrifugation.
DCS analysis demonstrated that the resulting NP-biomolecular corona complexes were well dispersed in 
plasma, and strikingly, despite expecting a shift upon the corona formation, we observed an overlap of the two 
distributions for the 5 nm Au-PMA and 5 nm Au-PMA-C (Fig. 1c,d, red line). Similar results were observed 
for 25 nm AuNPs, where a shift towards smaller diameter (left shift from the NP uncoated core) occurred when 
the NPs were coated with the PMA polymer (Fig. 1g,h—black and blue lines) but no sedimentation shift was 
observed between 25 nm Au-PMA and 25 nm Au-PMA-C (Fig. 1g,h, blue and red lines). However, a different 
behaviour was observed for the 50 nm diameter AuNPs, where a shift was observed between the pristine and the 
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Figure 2.  NP sedimentation time as a function of shell density and thickness. (a) Shown colour-coded is the 
fold-change in sedimentation time on a logarithmic scale (white to blue: faster, white to red: slower) relative to 
the sedimentation time of a bare NP without the shell. The sedimentation time is plotted double-logarithmically 
versus shell density and shell thickness. It was calculated using Eq. (1) by inserting the total (core plus shell) 
NP diameter, as well as the effective NP density ρeff  according to Eq. (2) (see “Methods” section). This plot uses 
normalised parameters in units ρfl = 1 (left vertical dashed line), dc = 1 , t(ds = 0) = 1 , and it assumes ρc = 10 
(right vertical dashed line). The qualitative behaviour shown remains valid for all ρc > ρfl . Indicated are also 
the critical shell density ρcrit (middle vertical dashed line), as well as the maximum sedimentation time (red 
dashed line) for shell densities in the range ρfl < ρs < ρcrit . (b) For different values of shell densities in the 
range ρfl < ρs < ρcrit, the fold-change in sedimentation time increases and decreases as a function of the shell 
thickness. The red circles and dashed line represent the maximum sedimentation time for a certain shell density. 
Note that in theory two different shell thickness can give rise to the same fold change > 1, which is not a concern 
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in situ in blood plasma (Fig. 1k,l, blue and red), confirming the presence of the biomolecular corona by means 
of the core shell model equations.
NP‑biomolecular corona validation. Based on these calculations, we found that the DCS is a reliable 
technique  for the quantification of the PMA shell thickness across different NP size ranges. However, the tech-
nique failed to detect a shift for the NPs-PMA-protein corona complexes for  f 5 and 25 nm sized particles of this 
particular density, highlighting a possible limitation of this technique.
This lack of shift in the measured diameter after sedimentation of 5 and 25 nm sized AuNPs could either 
implicate that the biomolecular corona forming around such small particles is rather a transient corona than 
the tightly and nearly irreversibly bound biomolecular layer i.e. “hard corona”, or that DCS may not be an ideal 
technique to resolve the NP-biomolecular corona complexes for small particles with a low density and the full 
characterisation would require different measuring techniques.
To address the presence of the biomolecular corona around 5 nm particles, we focused on the 5 nm Au-PMA 
particles and applied multiple methods to evaluate whether the strongly bound biomolecular corona is formed 
around these particles. For further characterisation, agarose gel electrophoresis (AGE) was applied, as the NPs 
generally migrate towards the anode as the travel through the gel pores, but any small changes in the particle 
surface, e.g. functionalisation with the organic ligands or indeed the biomolecular corona formation, might lead 
to a change in the electrophoretic mobility of the particles. Figure 3a shows that there is a clear electrophoretic 
mobility difference for the NPs after exposure to blood plasma, indicating that the formation of the corona influ-
ences the migration through the agarose gel, compared to the pristine ones.
The NPs with strongly bound biomolecular coronas, i.e. “hard corona” (HC) were isolated using centrifuga-
tion and we applied multiple washes to remove the unbound and loosely bound biomolecules from the  corona9. 
However, due to their small size, we used an ultracentrifugation with a sucrose cushion to sediment the NPs-
corona complexes. Briefly, after the incubation with human plasma, the NP-HC complexes were isolated by 
centrifugation using an ultracentrifuge for the 5 nm AuNP (55000 r.p.m., for 20 min) or a benchtop centrifuge 
for the 25 and 50 nm AuNP (5000 r.p.m., for 15 min) respectively, followed by 3 washes in phosphate buffered 
saline (PBS). The NP corona complexes were resuspended in PBS and characterised by Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) to determine the presence and composition of the corona. To 
effectively separate leftover plasma proteins in the case of 5 nm AuNP-Corona, we applied a sucrose density 
cushion (40% w/v aqueous sucrose solution). This was performed in all 3 washing steps.
As shown in Fig. 3b, the PMA coated gold particles across all sizes display a strongly bound biomolecular 
corona as a result of distinct bands present in the gel. In particular, whilst the 25 and 50 nm Au-PMA NPs display 
a similar corona fingerprint, the smaller particles (5 nm Au-PMA) show a significant difference in the corona 
composition, suggesting that the surface curvature plays a significant role in the biomolecular corona formation 
of small particles. This hypothesis is in agreement with previous studies in which the biomolecular coronas of 
the PMA-coated AuNPs of different core sizes have been  compared19.
Apart from the core size, the material of the particle core can significantly influence the biomolecular corona 
formation, e.g. due to the differences in density and inevitably different surface interactions attributable to differ-
ences in surface chemistry. However, for the polymer coated particles, this should not be the case, regardless of 
the core material. Hence, we explored the role of the particle core material in the biomolecular corona formation 
and we developed a series of inorganic particles with different core materials with the same core diameter, i.e. 
Figure 3.  Electrophoresis analysis of the NP corona complexes. (a) Agarose gel electrophoresis assessed in a 
2% (w/w) agarose gel of 5 nm AuNP before and after exposure to human plasma. The gel was visualized by a 
visible light scanner. (b) Silver stained SDS-PAGE gel showing the protein profile of the associated coronas for 
the different Au-PMA core sizes. The two lanes for each of the samples correspond to biological replicates, and 
the last one (C) represents the protein background (negative control). SDS-PAGE protein ladder corresponds to 
ColorPlus Prestained Protein Ladder, Broad Range (10–230 kDa) (New England Biolabs).
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5 nm namely, Ag, FePt NPs, and CdSn/ZnS quantum dots (QDs) all subsequently coated using the same PMA 
 polymer4. As shown in Fig. S1, the PMA coating induced a change in the sedimentation with respect to the pris-
tine particles for all materials tested. This is due to the change in the medium density as discussed previously, 
present in hybrid NPs composed out of an inorganic core and an organic polymer shell. Again, no additional 
shift occurred when these particles were exposed to the blood plasma, indicating that the sedimentation speed of 
the PMA and PMA-corona complexes was similar, in agreement with the 5 nm PMA coated AuNP . Similarly, to 
the 5 nm AuNP-PMA, also the PMA coated QDs resulted in a significant change in the electrophoretic mobility 
during the characterisation by agarose gel electrophoresis after exposure to blood plasma, indicating the presence 
of the biomolecular corona formation (Fig. S2). The biomolecular corona fingerprint was also characterised by  
SDS-PAGE, where a specific corona fingerprint was observed depending on the biological fluid used during the 
incubation step (e.g. FBS, human plasma) (Fig. S3).
Overall, using the DCS as an only tool for characterisation of the NP protein coronas would lead to an incor-
rect conclusion that the PMA coating leads to a corona repulsion in the case of 5 and 25 nm sized particles. In 
fact, the gel electrophoresis data shown in this study demonstrate the biomolecular corona formation around 
these NPs.
Application of the core–shell model. DCS has become a commonly used technique for the study of the 
particle dispersion properties in situ, evaluation of particle density, flotation properties, and even concentration 
 estimation13,33,38. In particular, when combined with the use of a one- or two-layer density core–shell model, the 
coating thickness of different layers of chemical or biological relevance can be estimated. Here we have applied 
such knowledge to the characterisation of the Au-PMA NPs before and after corona formation. As previously 
mentioned, the NP  diameter measured by the DCS is accurate only if the nanomaterial core density (ρc) is 
known (see the Methods section for the definition of the core–shell). For the case of gold, which has a density 
of 19.3 g  cm−3, by applying the core–shell model and solving Eq. (1), it is possible to calculate the true parti-
cle diameter. For sterically coated particles with polymers of lower density materials, a shift towards a smaller 
diameter is expected, as confirmed by the DCS measurements after the grafting process as an indication of the 
overall density change of the resulting coated NPs 13,39. In particular, for the AuNP shown in Fig. 1, after the 
PMA coating is applied, the density of the Au-PMA complex is reduced as the PMA layer has according to the 
applied core–shell model a density (ρs1) of 0.9 g  cm−3, which is significantly lower than the density of the gold 
core. By solving Eq. (4) for the net NP-core shell density (ρeff), we confirmed that the PMA coating induced a 
significant drop of the particle overall density. The reduction in particle density is particularly pronounced in the 
case of Au-PMA NPs of 5 nm diameter, where we observe a decrease in the density of more than 90% compared 
to before coating. For the 25 and 50 nm NPs the reduction is less evident, close to 60% and 40%, respectively 
(Table 2). This is expected as in case the thickness of the PMA shell remains constant for all the core sizes, its 
relative contribution to the overall NP volume is the smaller the bigger the NP cores are.
Overall, based on the core–shell model (Eq. (3)), the measured polymer shell thickness of all NPs was of ca. 
5.5 nm, indicate a similar coating regardless of the surface curvature. This is in good agreement with previous 
studies performed using different  techniques27.
Once the Au-PMA complex density and the thickness of the PMA layer were calculated, we subsequently esti-
mated the thickness of the biomolecular coating and the density of the Au-PMA-biomolecular corona complex 
by using the two-layer model (Eq. (3) together with Eq. (4)). We assume a density of 1.15 g  cm−3 for the protein 
layer as previously  reported13. The results of these calculations are presented in Table 2. Firstly, we observed that 
for the 5 nm AuNP, the model could not be used to predict the biomolecular corona shell thickness due to an 
almost negligible DCS diameter shift (Table 1) combined with the sharp decrease of the effective density of the 
NP-PMA complex (Table 2). On the other hand, for the 25 and 50 nm sized AuNPs, the model does predict a 
size for the biomolecular corona, however for the 25 nm sized particles the obtained value was much smaller 
than  expected40. To shed light on how the shift in the DCS diameter would predict a particular shell thickness 
for the PMA coating and the biomolecular corona complex, we calculated the expected shift for different com-
binations of PMA and protein corona thickness for the particle core sizes of 5 and 50 nm, using the core–shell 
model. The results are shown in Fig. 4, where each coloured band corresponds to a distinct range of the shift. In 
all cases, the density of the core, density of the PMA coating, and the biomolecular corona, were fixed to 19.3, 
0.9, and 1.15 g  cm−3, respectively.
For the 5 nm sized NPs, with a typical PMA coating of ca. 5 nm, and an average biomolecular corona of 5 nm 
thickness, a predicted shift in the measured diameter by the DCS would result between 0 and 0.2 nm because 
the opposing effects of the size increase and the reduced effective density nearly cancel each other  out13. This is 
Table 2.  PMA and PMA corona shell thickness on AuNPs calculated using a core shell model on DCS 
measurements. *PMA and biomolecular corona thickness are calculated by applying the core–shell model as 
indicated in the Methods section.
5 Au 25 Au 50 Au
Au-PMA ρeff[g  cm−3] 1.5 ± 0.1 7.7 ± 0.1 10.9 ± 0.2
PMA layer [nm]* 5.3 ± 0.5 5.3 ± 0.1 5.9 ± 0.2
Au-PMA-Corona ρeff [g  cm−3] – 7.2 ± 0.1 7.0 ± 0.4
Corona layer [nm]* – 0.5 ± 0.1 5.9 ± 0.9
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mainly due to the significant drop in the effective density of the resulting NP-polymer-corona complex, as the 
core which is usually larger than the outer layers contributes less to the total NP mass/density . It is also worth 
mentioning that smaller shifts than of 0.2 nm or less reach the limit of detection of the DCS analytical centri-
fuge, i.e., due to the instrument’s sensitivity, it would result indistinguishable by the standard deviation of the 
measurements. On the other hand, the same PMA layer and a biomolecular corona thickness of the 50 AuNP 
result in a theoretical change of the apparent diameter shift ranging between −3.5 nm and −3.0 nm, which is in 
agreement with the observed shift of -3.7 nm in our DCS measurements (Fig. 1).
Our core–shell model was applied for the estimation of the biomolecular layer on the surface of larger par-
ticles. In the case of the 50 nm Au-PMA the biomolecular corona layer of 5.7 nm was calculated, which is in 
agreement with previous estimates of the corona coatings by DCS, and with other  methods40. Herein, applied 
techniques are better suitable for NPs with larger cores, which is in contrast to the diffusion-based techniques, 
e.g. FCS, where the biomolecular corona can be more efficiently detected around particles with smaller cores. 
This makes the DCS technique particularly attractive, it is complementary to other techniques and yields reliable 
results under conditions where other techniques would most definitely fail.
Conclusion
In this article, we report a systematic study of the NP physico-chemical characterisation following the biomo-
lecular corona formation applied to a custom-designed  set of inorganic NPs where we varied the core size and 
material, and have applied  a surface coating with the PMA polymer, suitable for applications in nanomedicine. 
Our study shows that characterising small particle cores, i.e., 5 nm diameter with the DCS is not only experimen-
tally challenging, owing to their small size and decreased overall particle density due to the PMA coating that 
requires long sedimentation times, but also the NP-corona complexes are not resolved by DCS as their density 
is not significantly different from the same NP without the corona, leading to a similar sedimentation time.
The designed workflow helps to rationally identify, characterise, and isolate small NP-biomolecular corona 
complexes by tuning and custom modifying existing methodologies. We have shown how the nature of the ligand 
can significantly affect the direction of the shift in the apparent diameter during the DCS measurements, which 
can be used for extrapolation of the biomolecular corona thickness. We have highlighted the unlikelihood of fully 
resolving the apparent diameter shift for very small NPs, where current models and approaches developed and 
readily applicable for larger NPs fail to confidently separate populations, even with high resolution instruments 
such as the DCS analytical centrifuge.
Methods
Nanoparticle synthesis and characterisation methods. Gold nanoparticles of 5 nm nominal core 
diameter were synthesised using the Brust-Schifrin  method35. Subsequently, they were initially functionalised 
with the dodecanethiol and then transferred to aqueous phase by using the polymer coating technique coating 
the particles with the poly-(isobutylene-alt-maleic anhydride)-graft-dodecyl polymer (PMA).
Gold nanoparticles of 25 and 50 nm nominal core diameters were synthesised using the method reported by 
Bastús41, and subsequently transferred to chloroform and stabilised with dodecanethiol using the methodology 
reported by Soliman et al.26 and finally coated with the PMA polymer. The remaining nanoparticles (PMA coated 
FePt, Ag and CdSe/ZnS QDs) were synthetised according to a published  protocol4.
All particles were characterised by UV–Vis absorption spectroscopy (Agilent 8453 spectrometer), inductively 
coupled plasma mass spectrometry (ICP-MS; Agilent 7700 series ICP-MS), TEM (Jeol 1400 plus), DLS (Nano-
sizer, Malvern), and in the case of water-soluble NPs via laser Doppler anemometry. The NP size distribution 
Figure 4.  Predicted shift according to the core–shell model for different combinations PMA and corona 
thicknesses. (a) 5 nm and (b) 50 nm NP. Each coloured area corresponds to a predicted range of the shift.
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by TEM was obtained by imaging 279, 131 and 100 particles for 5 nm, 25 nm and 50 nm respectively and the 
images were processed by Image J software.
Differential centrifugal sedimentation (DCS).  The NP size distributions were analysed in dispersion 
using a CPS disc centrifuge DC24000 (CPS Instruments Inc.) using the appropriate density gradients depend-
ing on the nature of the sample. Sucrose solutions of 2–8% (w/v) with the density of 1.018 g  cm−3, or 8–24% 
with the density of 1.064 g  cm−3 (w/v) were used for the measurements of NPs with 5 nm core diameters and 
larger NPs, respectively and prepared in Milli-Q water or PBS for the measurements of the corona complexes, 
in situ, at pH 7.4. Sucrose solutions were prepared fresh and filled successively in nine consecutive steps into the 
disc, rotating at the speed set to 24000 r.p.m., starting with the highest density, according to the manufacturer’s 
guidance. Calibration was performed using a calibration standard, PVC 483 nm (Analytik Ltd.) before each 
analysis. Measurements were performed in a measurement range between 0 and 500 nm. The samples with the 
biomolecular corona were directly injected into the disc centrifuge without prefractionation or separation, to 
allow for the in situ analysis. Measurements of the hydrophobic NP cores dispersed in the organic solvent were 
performed using a toluene-based halocarbon density gradient composed by two solutions of 85% toluene + 5% 
Halocarbon 1.8 (w/w) and 95% toluene + 15% Halocarbon 1.8 (w/w) with resulting density of 0.915 g  cm−3. In 
this case, diamond particles of 516 nm diameter were used as standard for measurements.
Biomolecular corona preparation. The biomolecular corona preparation was carried out following a 
published  method12. Briefly, the human plasma used for the biomolecular corona studies was obtained from 
the Irish blood transfusion service (IBTS) based in Saint James Hospital Dublin. The blood was collected from 
female and male healthy donors and processed by the IBTS. Formation of the biomolecular corona was per-
formed for 1 h at 37 °C to allow the equilibration of the biomolecular corona, the ratio total surface area to 
protein was fixed in order to compare between NPs. The surface area of each NP applied was 2.5 ×  1015  nm2 in a 
total of 500 μL, making a final surface area of 5 ×  1015  nm2  mL−1.
Agarose gel electrophoresis. Agarose gel electrophoresis was used to determine the interaction between 
the NPs and plasma proteins by measuring the NP electrophoretic mobility  prior and after exposure to the bio-
logical media. The NP electrophoretic mobility was assessed using a 2% (w/w) low melting point agarose gel in 
Tris EDTA Buffer. A 50× Tris EDTA buffer stock was prepared by dissolving 24.2 g Trizma Base and 10 mL 0.5 M 
EDTA in 100 mL of Milli-Q water. Agarose was dissolved in 125 mL of 1× Tris EDTA buffer, after adjusting the 
pH to 8.5 with HCl, by heating in a microwave for 2 min and sonicated for 20 s.
NPs were incubated with the increasing plasma concentrations diluted in PBS buffer (10–100% blood plasma) 
and incubated for 1 h at 37 °C under shaking conditions. Subsequently, four parts of the sample were mixed with 
1 part of Loading Buffer (36% v/v 5× Tris EDTA buffer, 50% glycerol, 0.01% w/v Bromophenol Blue) and 40 µL 
of this solution was loaded in each well. The electrophoresis was performed at 130 V in 1× Tris EDTA buffer 
for 90 min using a BioRad Agarose Electrophoretic System on ice to avoid overheating and melting of the gel.
Isolation of the biomolecular coronas. Isolation of small NP-biomolecular corona complexes for the 
SDS-PAGE analysis were isolated using ultracentrifugation with a Beckman Coulter OptimaMax XP Ultracen-
trifuge equipped with a MLA-130 rotor, applying a cushion of 500 μL of 40% sucrose (w/v) solution to separate 
free proteins, the sample was dispensed on top and spun down for 30 min at 55000   r.p.m., the supernatant 
was removed, and the pellet was redispersed in 1× PBS. Three washes were performed in the same way. Larger 
NPs were spun down at 5000 r.p.m for 15 min and 3 washes in 1× PBS were performed prior to loading in 1D 
SDS-PAGE (10%) and run for 1 h at 130 V. The pellets were re-dispersed in PBS and mixed with 3× loading 
buffer (62.5 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 10% glycerol, 0.04 M DTT and 0.01% (w/v) bromophenol 
blue), heated at 95 °C for 5 min and loaded for running. As molecular weight marker it was used the ColorPlus 
Prestained Protein Ladder, Broad Range (10–230 kDa) (New England Biolabs).
Core‑shell model analysis. The core-shell model analysis was carried out using an in-house written code 
where Eq. (4), along with Eq. (2), for a one-layer system, or Eq. (3), for the two-layer system, are numerically 
solved and Fig. 4 was obtained using the matplotlib library in Python. The numerical solution was needed as 
the equation to obtain the thickness is a polynomial of third order. It is worth noting that the densities of the 
core and each of the coating layers, PMA and biomolecule, are input parameters of the model. Also note that for 
a two-layer system, the thickness of the first layer is first calculated and the resulting value is then used in the 
calculation of the thickness of the second layer. These effective densities cannot be directly measured experimen-
tally because their values are dependent on dc, the densities of all the components of the NP (core and the layers) 
and the thickness  (s1 and  s2) of the shells.
The following density values were used for the core shell model calculations: AgNPs (10.5 g  cm−3), FePt 
NPs (4.0 g  cm−3)42, CdSe/ZnS QDs (6.0 g  cm−3), density of the PMA layer ρs1 = 0.9 g  cm−3 and density of the 
biomolecular corona coating ( ρs2) = 1.15 g  cm−333. The density of the fluids was 1.018 g  cm−3 for the 5 nm NP 
measurements and 1.064 g  cm−3 for the remaining measurements.
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